Results

eNauka >  Results >  Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial
Title: Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial
Authors Delaloge, Suzette; ...; Filipovic, Sladjana; ...; (broj, koautora 28)
Issue Date: 2019
Publication: ANNALS OF ONCOLOGY
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Article
Collation: vol. 30 br. 4 str. 567-574
DOI: 10.1093/annonc/mdz016
WoS-ID: 000468283900012
Scopus-ID: 2-s2.0-85062243680
URI: https://enauka.gov.rs/handle/123456789/818138
Project: Wyeth Healthcare
Pfizer Inc, New York, USA
Puma Biotechnology Inc., Los Angeles, CA, USA
Puma Biotechnology Inc.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21a+M21a+

23
SCOPUSTM
13
OpenCitations
21
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.